(Q35186715)

7 August 2017

1 reference

title

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors (English)

1 reference

7 August 2017

1 reference

1 reference

Avery A Sandberg

1

1 reference

7 August 2017

Julia A Bridge

series ordinal

2

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Cancer Genetics and Cytogenetics

7 August 2017

published in

1 reference

7 August 2017

volume

145

1 reference

7 August 2017

issue

1

1 reference

7 August 2017

page(s)

1-30

1 reference

Pathology of Osteosarcoma

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Osteogenic sarcoma with clinically detectable metastasis at initial presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

1 reference

7 January 2021

Postirradiation sarcomas. A single-institution study and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Orthopaedic implant-related sarcoma: a study of twelve cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Second primary neoplasms in patients with retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Common musculoskeletal tumors of childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Osteosarcoma of bone and its important recognizable varieties

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Tumor size and prognosis in aggressively treated osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Current treatment of osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

New aspects of cell biology in osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Extraskeletal osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Contribution of molecular genetic data to the classification of sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

A survey of telomerase activity in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Role of telomerase in normal and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Telomeres, telomerase, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Alternative lengthening of telomeres in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Malignancy after retinoblastoma: Secondary cancer or recurrence?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Osteosarcoma following retinoblastoma: age at onset and latency period.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Pleiotropic effects of the gene for retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Studies of the RB1 gene and the p53 gene in human osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Alterations of the p53, Rb and MDM2 genes in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Alteration of pRb/p16/cdk4 regulation in human osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

A microsatellite fluorescent method for linkage analysis in familial retinoblastoma and deletion detection at the RB1 locus in retinoblastoma and osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Role of the Rb/E2F pathway in cell growth control

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Altered G1 phase regulation in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Molecular alterations of the RB1, TP53, and MDM2 genes in primary and xenografted human osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Characterization of a highly conserved gene (OS4) amplified with CDK4 in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

MDM2 and CDK4 gene amplification in Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Complexity of 12q13-22 amplicon in liposarcoma: microsatellite repeat analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Regulation of p53 downstream genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Chromosome analysis of nine osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

p53; from inductive signal to cellular effect

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Inactivation of p53 gene in human and murine osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

p53 functions as a cell cycle control protein in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Rearrangement of the p53 gene in human osteogenic sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Alterations of the p15, p16,and p18 genes in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Mechanisms of p53 loss in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Amplification of a gene encoding a p53-associated protein in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Allelic Losses from Chromosome 17 in Human Osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Analysis of p53 expression in osteosarcoma of the jaw: correlation with clinicopathologic and DNA ploidy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

p53 gene mutations in osteosarcomas of low-grade malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Detection of TP53 gene mutations in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Tumor spectrum analysis in p53-mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Correlation between apoptosis and TP53 status in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

The MDM2 gene amplification database

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

MDM2 gene amplification in bone and soft‐tissue tumors: Association with tumor progression in differentiated adipose‐tissue tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Osteosarcoma versus malignant fibrous histiocytoma of bone in patients older than 40 years. A clinicopathologic and immunohistochemical analysis with special reference to malignant fibrous histiocytoma-like osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Splicing into senescence: the curious case of p16 and p19ARF.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Osteosarcoma and other bone cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Frequent reduction or loss of DCC gene expression in human osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Common mechanisms of osteosarcoma and Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Microarray analysis of Tbx2-directed gene expression: a possible role in osteogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cloning and expression analysis of the mouse T-box gene Tbx18.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Amplification of a rearranged form of the high-mobility group protein gene HMGIC in OsA-CI osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

The tumor-associated gene HMGIC is expressed in normal and osteoarthritis-affected synovia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cell and molecular biology of simian virus 40: implications for human infections and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Integration of SV40 in human osteosarcoma DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Amplifications of DNA primase 1 (PRIM1) in human osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Transcript mapping in a 46-kb sequenced region at the core of 12q13.3 amplification in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Isolation of osteosarcoma-associated amplified DNA sequences using representational difference analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

MYC oncogenes and human neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Clinicopathologic correlations and short-term prognosis in musculoskeletal sarcoma with c-myc oncogene amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Correlation of c-fos, p53, and PCNA expression with treatment outcome in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Expression of HER2/erbB-2 correlates with survival in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

ErbB2 expression is correlated with increased survival of patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Redundancy of autocrine loops in human osteosarcoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Accumulation of E2F-4.DP-1 DNA binding complexes correlates with induction of dhfr gene expression during the G1 to S phase transition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Topoisomerases, new targets in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Biology of the multidrug resistance-associated protein, MRP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Amplification and organization of dihydrofolate reductase genes in a human leukemic cell line, K-562, resistant to methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Dihydrofolate reductase as a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Prognostic value of serum alkaline phosphatase in osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Prognostic significance of bone morphogenetic activity in osteosarcoma tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Rosette-forming epithelioid osteosarcoma: a histologic subtype with highly aggressive clinical behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Prognostic factors for sarcomas: hard and soft

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Quantitative analysis of multidrug resistance gene expression in human osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

P-glycoprotein and multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

MDR1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Multidrug resistance in acute leukemia: a comparison of different diagnostic methods

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cellular DNA content in human osteosarcoma: aspects on diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Flow DNA analysis of primary bone tumors. Relationship between cellular DNA content and histopathologic classification

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Prognostic significance of DNA ploidy pattern in osteosarcomas in association with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Clinical relevance of Ki-67 expression in bone tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Telomerase in cancer and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Telomerase activity in skeletal sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Telomerase activity in benign bone tumors and tumor-like lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Complex karyotypes in a series of pediatric osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cytogenetic findings in 33 osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Report of the first international workshop on human chromosome 12 mapping.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cytogenetic findings in 19 malignant bone tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cytogenetic investigations of solid tumours of children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Inversion (6)(p23q15) as the sole anomaly in a low-grade intraosseous osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cytogenetic studies on fine-needle aspiration samples from osteosarcoma and Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Comparison of cytogenetics, interphase cytogenetics, and DNA flow cytometry in bone tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Chromosomal instability in osteosarcoma and its association with centrosome abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Computer image analysis of comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Chromosomal regions involved in the pathogenesis of osteosarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

DNA copy number amplifications in sarcomas with homogeneously staining regions and double minutes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Comparative genomic hybridization analysis identifies gains of 1p35∼p36 and chromosome 19 in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

No evidence of microsatellite instability in bone tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Molecular cytogenetics of bone and soft tissue tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Characterization of the 17p amplicon in human sarcomas: Microsatellite marker analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Aberrations of chromosomes 1 and 17 in six human osteosarcoma cell lines using double-target fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Relationship between chromosomal aberrations by fluorescence in situ hybridization and DNA ploidy by cytofluorometry in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Osteosarcoma oncogene expression detected by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Novel findings in gene expression detected in human osteosarcoma by cDNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Ring chromosome in parosteal osteosarcoma. Clinical and diagnostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Parosteal osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Giant cell rich parosteal osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

SAS is amplified predominantly in surface osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021

Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma. A Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900105-5

7 January 2021